×
Back to Agenda
Session 7: Strategies for Global Drug Development
Session Chair(s)
Younglim Kim, PhD
Director General, National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Speaker(s)
Giljong Kang
, C & O Pharma Consultants, United States
CMC Information recommended for INDs and NDAs
Kyounghee Seo
, Hanmi , Korea, Republic of
Hanmi Footprints & Reshaping for Global Clinical Trials
Hae-Young Ahn, PhD
President, Ahn Bio, United States
Patient Centric Drug Development and Approval Factors Affecting Dose and Dosing Regimen
Ho Jung Oh
Director NIFDS, Ministry of Food and Drug Safety, Korea, Republic of
Have an account?